mined by a microbroth dilution method. The medium used was cation-adjusted Mueller-Hinton broth (Difco, Detroit, MI, USA) supplemented with 5% lysed horse blood and the inoculum was 10 8 cfu/L. The MICs were determined following incubation at 35ºC for 18 h.
Six of the 10 isolates were identified as E. faecium (four of which expressed the VanA phenotype and two the VanB phenotype) and the remaining four as Enterococcus gallinarum (all expressing the VanC phenotype). Although strains belonging to the latter species exhibit intermediate susceptibility to vancomycin and are not, therefore, resistant in the strictest sense, for the purpose of the present study they have been regarded as VRE.
The susceptibility test results for the 10 isolates are summarized in the Table. Of the 11 antibiotics evaluated, linezolid was the only one to which all 10 strains were susceptible. Quinupristin/dalfopristin was the next most active drug, with seven strains being categorized as susceptible. Although breakpoints for SCH 27899 had not been published at the time the study was undertaken, thereby precluding the assigning of susceptibility categories, the MICs for eight isolates were р0.5 mg/L and, for the remaining two isolates, 4 mg/L. Predictably, the strains expressing the VanA phenotype were uniformly resistant to teicoplanin, whereas those expressing the VanB or VanC phenotype were uniformly susceptible. For most of the antibiotics evaluated, there were marked differences between the E. faecium and E. gallinarum strains in terms of their susceptibility patterns. All six of the E. faecium strains were susceptible to quinupristin/dalfopristin, compared with only one of the E. gallinarum strains. On the other hand, all of the latter but none of the former were susceptible to imipenem and ampicillin. In addition, three of the four E. gallinarum strains were susceptible to clarithromycin, compared with only one of the E. faecium strains, and all four E. gallinarum strains exhibited low-level resistance to gentamicin, compared with only two E. faecium strains. Breakpoints for arbekacin were not available, but the MICs of this aminoglycoside for all of the E. gallinarum isolates were 4 mg/L, while those for the E. faecium isolates ranged from 8 to 128 mg/L. Less marked differences were observed with minocycline (two of four E. gallinarum and one of six E. faecium strains being susceptible) and SCH 27899 (MICs р 0.5 mg/L for the four E. gallinarum isolates and four of six E. faecium isolates).
It is apparent from the results of this study that the number of antibiotics, either currently available or in various stages of development, with in-vitro activity against VRE is limited. This applies particularly to isolates of E. a According to the following MIC breakpoints for susceptibility: vancomycin, р4 mg/L; teicoplanin, р8 mg/L; clarithromycin, р2 mg/L; gentamicin, р500 mg/L (differentiates between low-and high-level resistance, rather than between susceptibility and resistance); imipenem, р4 mg/L; ampicillin, р8 mg/L; minocycline, р4 mg/L; quinupristin/dalfopristin, р1 mg/L; and linezolid, р2 mg/L. These breakpoints are those recommended by the NCCLS, 4,5 the exceptions being tentative breakpoints for quinupristin/dalfopristin, recommended by Barry et al., 6 and linezolid, recommended by Wise et al. 7 There are no published breakpoints for SCH 27899 and arbekacin.
Naturally occurring antibacterial activities of avian and crocodile tissues
includes the synthesis and secretion of naturally occurring antimicrobial peptides. 1 The existence of these peptides was first recognized in invertebrates, with the discovery of cecropins in the silkmoth, 2 and was subsequently confirmed by the isolation of magainin from frog skin. 3 Since these discoveries, more than 200 antibacterial compounds have been detected in many different species, including humans.
The emergence of multidrug-resistant bacterial pathogens and the corresponding decline in the number of antibiotics available as treatment of patients with infections caused by them underscores the need to identify novel antimicrobial agents. Yet, no new class of antibacterials has been introduced into clinical practice during the past two decades. 4 Naturally occurring peptides with antibacterial properties have exhibited impressive in-vitro activities against microorganisms resistant to conventional antibiotics 5 and may therefore represent a new therapeutic modality. In the present study, we have screened a range of tissues from wild and domestic birds and reptiles for the presence of antibacterial activities.
The animals studied were vultures (Coragyps atratus foetens), ravens (Corvus corax), crocodiles (Crocodilus niloticus), ostriches (Struthio camelus), turkeys (Meleagris gallopavo) and chickens (Galus galus); these animals were chosen on the basis that, in their natural habitats, they are constantly exposed to a wide range of pathogenic bacteria. The tissues that were assessed included the following: stomach, duodenum, jejunum, colon, lung, liver, brain, heart, adrenal gland, muscle and blood. Following dissection (and manual cleansing of gastrointestinal tract organs), the tissues were frozen at -70°C. They were subsequently lyophilized and pulverized with a mortar and pestle. The resultant powder was suspended in 10% acetic acid and the suspension boiled for 15 min, followed by cooling to room temperature and centrifugation at 23,000g for 30 min at 10°C. The supernatant was applied to a solid phase extraction column LC-18 (5 gr-Supelco, Bellafonte, PA, USA) and the cartridges were washed with 20 mL of 0.1% trifluoroacetic acid (TFA) in water, followed by 20 mL of 0.1% TFA in 10% acetonitrile. Elution was performed with 0.1% TFA, first in 40% acetonitrile and then 80% acetonitrile. The fractions were collected in 1 mL volumes and vacuum dried. At the time of testing, they were resuspended in 80 L of sterile water. Antibacterial activity was detected and semi-quantified by a zone inhibition assay described previously 6 with Micrococcus luteus as the indicator organism; muscle tissue was used as a negative control.
The results of the screen are summarized in the Table; only data for those tissues exhibiting antibacterial activities are shown. At least one tissue from each of the avian species tested exhibited some antibacterial activity, the raven possessing the largest number of tissues with antibacterial activities, as well as the tissues exhibiting the most potent activities. This may be because the food on which ravens live tends to be highly contaminated. Unexpectedly, only a small number of the tissues from vultures, which also exist on highly contaminated food, demonstrated antibacterial activities and these activities were comparatively modest. For the most part, the tissues which most consistently exhibited antibacterial activities and which exhibited the most potent activities were those most likely to be exposed to pathogenic bacteria, i.e. lung and gastrointestinal tract tissues.
All of the tissues that exhibited antibacterial activities lost their activities following incubation in the presence of the peptidase, pronase, at a concentration of 1 g/L in Tris-HCl buffer, pH 7, for 2 h at 37°C. On the other hand, most of the tissues retained their antibacterial activities after immersion in boiling water for 15 min. These observations are consistent with the antibacterial agents being small peptides.
To the best of our knowledge, this is the first study that has demonstrated the presence of naturally occurring antibacterial agents in avian tissues. Focusing on species that are normally exposed to large numbers of potentially 417 pathogenic bacteria appears to be a good starting point in the search for such compounds. Our observations also suggest that future searches should concentrate on the tissues of those organs that normally tend to be extensively exposed to bacterial pathogens, i.e. those of the lungs and the gastrointestinal tract.
Sir, The so-called 'paradoxical effect', whereby antibiotics exhibit reduced bactericidal activities at high drug concentrations, has been observed mainly, although not exclusively, with -lactams and Gram-positive bacteria. 1 The phenomenon was first described by Eagle & Musselman 2 who found that Staphylococcus aureus, -haemolytic streptococci and, most strikingly, Enterococcus faecalis were killed much more slowly by high concentrations of benzylpenicillin than by lower (but still supra-MIC) concentrations.
The data sheets for many antibiotics recommend the administration of higher dosages when an infection is deemed 'serious' and it is apparent that for -lactam antibiotics in particular, there is a theoretical risk that this practice may not always be beneficial to the patient. For this reason, we have investigated the 'Eagle effect' as part of the microbiological evaluation of the novel penem, Men 10700.
The bacteria used in the study-S. aureus strains 957, 17090 and 17285 (all methicillin-susceptible -lactamase producers) and E. faecalis strains Lyons and FTS8-were clinical isolates used in previous studies. 3 Men 10700 was obtained from Menarini Ricerche SpA (Florence, Italy), and imipenem, cefotaxime and amoxycillin were obtained from Merck Sharp & Dohme (Hoddesdon, UK), Roussel Laboratories (Uxbridge, UK) and SmithKline Beecham (Welwyn Garden City, UK), respectively. MICs were determined by a standard broth dilution method; the medium used was IsoSensitest broth (ISB; Unipath, Basingstoke, UK) and the inocula were between 5 ϫ 10 9 and 5 ϫ 10 10 cfu/L. The bactericidal activities of Men 10700, imipenem and cefotaxime against the S. aureus strains, and Men 10700, amoxycillin and imipenem against the E. faecalis strains were investigated by time-kill studies. Overnight cultures of each bacterium (containing 7-11 ϫ 10 11 cfu/L) were diluted 1:10 in ISB, and 10 mL volumes were added to groups of five 25 mL conical flasks. For each antibiotic/bacterium combination, antibiotic was added to four flasks, giving final concentrations of 3 ϫ, 10 ϫ, 30 ϫ or 100 ϫ MIC; the fifth flask was a growth control. The flasks were shaken at 100 rpm at 37°C, and aliquots were withdrawn at 0, 4 and 24 h and inoculated on to nutrient agar plates (Unipath). Colonies were counted after incubation for 24 h and again after 48 h. From plots of log viable count versus time, the times taken to bring about 90% and 99.9% kill (t 90 and t 99.9 , respectively) and the percentages of the original inoculum surviving at 4 and 24 h were calculated.
For the three strains of S. aureus incubated in the presence of Men 10700, cefotaxime or imipenem, the time-kill curves were virtually linear between 0 and 24 h, although strain 17285 was killed up to three-fold more slowly depending on the antibiotic and the concentration, than the other two strains (data not shown). There was no reduction in the rates of killing at higher concentrations of cefotaxime, but as the concentration of Men 10700 increased from 3 ϫ to 100 ϫ MIC, there was a 38% decrease in t 99.9 for strain 957 only. On the other hand, imipenem at higher concentrations became less rapidly bactericidal against all three strains (t 99.9 being reduced by 30-52%), particularly 17285. Analysis of the survival rates (the original method used to define the Eagle effect 2 ) revealed no paradoxical effects at higher concentrations after 4 h, whereas after 24 h (Table) , the pattern was similar to that observed with the time-kill plots, i.e. no effect with cefotaxime, a modest effect (three-fold increased survival) with Men 10700 against strain 957, and a marked effect (13-fold increased survival) with imipenem against strain 17285.
In contrast to S. aureus, the time-kill curves for each of the E. faecalis strains were not linear, the rates of killing produced by the three antibiotics tested decreasing with time (data not shown). The survival data (Table) show marked paradoxical effects for all three drugs with both strains. When the effects of the lowest and highest concentrations are compared, the greatest (у100-fold) increases in the percentages of survivors were observed when amoxycillin was tested against both strains and when Men 10700 was tested against strain FTS8.
As E. faecalis is killed only slowly by antibiotics, the MBC, as defined conventionally (i.e. у99.9% killing), is often not achieved. 4 Consequently, most of these drugs are regarded as having only bacteriostatic activities against strains belonging to this species. None the less, time-kill studies such as those described here reveal that some antibiotics have, albeit slow, bactericidal activities which are concentration dependent.
Not all of the paradoxical effects produced by -lactam antibiotics that have been reported in the literature 5, 6 are synonymous with the classic Eagle effect. The absence of autolytic enzymes, which is regarded as the basis of tolerance, may, in part, also account for this effect in enterococci, 4 although tolerance appears to be a very different phenomenon. 7 The Eagle effect is measured by comparing the percentages of survivors after varying periods of exposure to an antibiotic at high and low concentrations. Provided the time-kill plots are linear (as observed in this study with the S. aureus strains), the effect can be quantified from the t 90 s or t 99.9 s, but this does not apply if the time-kill plots are dog-legged (as occurred with the E. faecalis strains).
We have observed a marked Eagle effect in enterococci with the penam, penem and carbapenem antibiotics tested, but, at most, only a marginal effect in S. aureus. The common practice of increasing the dosages of antibiotics in seriously ill patients should not therefore compromise the bactericidal activities of these drugs against the latter pathogen, but may not be appropriate in patients with certain enterococcal infections, e.g. infective endocarditis. 
